Vimarsana
Biggest News Aggregation in the World

Luisa Hill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Luisa Hill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Luisa Hill Today - Breaking & Trending Today

PTC Therapeutics' (PTCT) "Maintains" Rating Reiterated at 1-800-FLOWERS.COM - Vimarsana News

PTC Therapeutics' (PTCT) "Maintains" Rating Reiterated at 1-800-FLOWERS.COM

1-800-FLOWERS.COM reiterated their maintains rating on shares of PTC Therapeutics (NASDAQ:PTCT – Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. Other research analysts also recently issued research reports about the stock. Royal Bank of Canada upped their price objective on shares of PTC Therapeutics from $44.00 to $51.00 in a […]

Credit Suisse Group Trims PTC Therapeutics (NASDAQ:PTCT) Target Price to $50.00 - Vimarsana News

Credit Suisse Group Trims PTC Therapeutics (NASDAQ:PTCT) Target Price to $50.00

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price decreased by Credit Suisse Group from $55.00 to $50.00 in a research note published on Wednesday, The Fly reports. A number of other equities research analysts also recently issued reports on the stock. StockNews.com initiated coverage on shares of PTC Therapeutics in a research report […]

Source: wkrb13.com
PTC Therapeutics (NASDAQ:PTCT) Coverage Initiated at StockNews.com - Vimarsana News

PTC Therapeutics (NASDAQ:PTCT) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of PTC Therapeutics (NASDAQ:PTCT – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other research analysts also recently commented on PTCT. Morgan Stanley boosted their price target on PTC Therapeutics from $40.00 to […]

Source: wkrb13.com
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $53.79 Average PT from Analysts - Vimarsana News

PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $53.79 Average PT from Analysts

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) has been given a consensus recommendation of “Hold” by the sixteen brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have assigned a buy recommendation to the company. The average […]

PTC Therapeutics (NASDAQ:PTCT) PT Raised to $51.00 at Credit Suisse Group - Vimarsana News

PTC Therapeutics (NASDAQ:PTCT) PT Raised to $51.00 at Credit Suisse Group

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price upped by stock analysts at Credit Suisse Group from $48.00 to $51.00 in a report issued on Friday, The Fly reports. Credit Suisse Group’s target price would suggest a potential downside of 7.51% from the company’s previous close. Other analysts have also recently issued research […]